SCHEMBL7589858

SCHEMBL7589858

O=C(O)c1cc([N+](=O)[O-])cc(Br)c1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C19 P33261 2/20 0.48
MAPT P10636 4/20 0.44
CYP3A4 P08684 3/20 0.44
ALOX15 P16050 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPK1 P28482 2/20 0.43
LMNA P02545 2/20 0.42
TP53 P04637 2/20 0.41
HTT P42858 1/20 0.41
CTSV O60911 1/20 0.41
CTSL P07711 1/20 0.41
KMT2A Q03164 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MEN1 O00255 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
PLA2G1B P04054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13531820 0.87 ALDH1A1 (0.54) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL7587383 0.86 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL2034609 0.82 ALDH1A1 (0.64) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL27480347 0.81 ALDH1A1 (0.41) ALDH1A1MAPTCYP3A4LMNAHTT
SCHEMBL7582706 0.81 ALDH1A1 (0.41) ALDH1A1MAPTCYP3A4TDP1MAPK1
SCHEMBL1487913 0.81 CA1 (0.53) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT
SCHEMBL19357885 0.81 CA1 (0.49) ALDH1A1CYP1A2MAPTCYP3A4ALOX15
SCHEMBL8841205 0.80 ALDH1A1 (0.50) ALDH1A1MAPTCYP3A4ALOX15TDP1
SCHEMBL25287029 0.79 ALDH1A1 (0.44) ALDH1A1MAPTCYP3A4ALOX15TDP1
SCHEMBL22032848 0.79 ALDH1A1 (0.46) ALDH1A1CYP1A2CYP2D6CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102427726-B fused ring inhibitors of hepatitis c PRESIDIO PHARMACEUTICALS, INC. (US) 2014-10-08 CN disclosed
CN-103596951-A 8-ethyl-6-(aryl)pyrido [2,3-d]pyrimidin-7(8h)-ones for the treatment of nervous system disorders and cancer AFRAXIS INC 2014-02-19 CN disclosed
CN-1114596-C Biphenyl derivatives EISAI CO LTD (JP) 2003-07-16 CN disclosed
EP-0675118-B1 Biphenylderivatives, process for their preparation and their use as medicaments EISAI CO LTD (JP) 2002-10-09 EP disclosed
US-6281214-B1 USEFUL FOR TREATING AND AMELIORATING MENTAL DISORDERS EISAI CO., LTD (JP) 2001-08-28 US disclosed
CN-1290700-A Phenyl piperazine derivatives EISAI LTD (JP) 2001-04-11 CN disclosed
US-5849912-A Biphenyl derivatives EISAI CO., LTD. (JP) 1998-12-15 US disclosed
CN-1117966-A Biphenyl derivatives EISAI CO LTD (JP) 1996-03-06 CN disclosed
EP-0675118-A2 Biphenylderivatives, process for their preparation and their use as medicaments Eisai Co., Ltd. (JP) 1995-10-04 EP disclosed